Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
652-01-006 / 652-01-006 ISMRM Abstract

Incremental Value of Epicardial Adipose Tissue to Predict Major Adverse Cardiovascular Events in Hypertrophic Cardiomyopathy

Primary: Cardiovascular - Myocardium
Secondary: Cardiovascular - Atherosclerosis
652-01-006 · Prognostication and Predictive Value of MR Biomarkers · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 2
652-01-006 · Prognostication and Predictive Value of MR Biomarkers · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 2
Keywords: Hypertrophic cardiomyopathy Epicardial adipose tissue Prognosis Major adverse cardiovascular events
Accepted
Yipei Song 1, Mengyao Hu1, Qimin Fang1, Jiankun Dai2, Lianggeng Gong1
1The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China
2MR Research, Beijing, China
Presenting Author: Yipei Song

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Maron, B. J. & Maron, M. S. Hypertrophic cardiomyopathy. Lancet 381, 242-255, doi:10.1016/S0140-6736(12)60397-3 (2013). [doi]
2. Iacobellis, G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol 19, 593-606, doi:10.1038/s41569-022-00679-9 (2022). [doi]
3. Konwerski, M., Gasecka, A., Opolski, G., Grabowski, M. & Mazurek, T. Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review. Biology (Basel) 11, doi:10.3390/biology11030355 (2022). [doi]
4. Fluchter, S. et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring) 15, 870-878, doi:10.1038/oby.2007.591 (2007). [doi]
5. Guglielmo, M. et al. DEep LearnIng-based QuaNtification of epicardial adipose tissue predicts MACE in patients undergoing stress CMR. Atherosclerosis 397, 117549, doi:10.1016/j.atherosclerosis.2024.117549 (2024). [doi]
6. ary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142, e533-e557, doi:10.1161/CIR.0000000000000938 (2020). [doi]
7. Wang, J. et al. Influence of phenotype conversion of epicardial adipocytes on the coronary atherosclerosis and its potential molecular mechanism. Am J Transl Res 7, 1712-1723 (2015).
8. Wu, J. G., Yang, W. K., Huang, H. Z., Tang, K. & Zheng, G. D. MiRNA-6870-3p Regulates Lipopolysaccharide Induced Epicardial Adipose Tissue Inflammatory Genes via Targeting Tollip-Mediated JNK and NF-kappaB Signaling in Coronary Artery Disease. Int Heart J 63, 915-927, doi:10.1536/ihj.22-163 (2022). [doi]
9. Diaz-Rodriguez, E. et al. Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability. Cardiovasc Res 114, 336-346, doi:10.1093/cvr/cvx186 (2018). [doi]
10. Launbo, N. et al. Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: A systematic review and meta-analysis. Obes Rev 22, e13136, doi:10.1111/obr.13136 (2021). [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/652-01-006